SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $78,000 | -18.8% | 80,924 | +0.0% | 0.00% | – |
| Q1 2022 | $96,000 | -70.9% | 80,884 | -20.1% | 0.00% | – |
| Q4 2021 | $330,000 | +50.7% | 101,284 | +106.3% | 0.00% | – |
| Q3 2021 | $219,000 | -57.6% | 49,084 | +3.1% | 0.00% | – |
| Q4 2020 | $516,000 | +41.4% | 47,593 | +15.2% | 0.00% | – |
| Q3 2020 | $365,000 | +52.1% | 41,303 | +83.5% | 0.00% | – |
| Q2 2020 | $240,000 | -53.5% | 22,503 | -74.1% | 0.00% | – |
| Q1 2020 | $516,000 | +75.5% | 87,052 | +104.8% | 0.00% | – |
| Q4 2019 | $294,000 | -63.3% | 42,498 | -44.9% | 0.00% | – |
| Q3 2019 | $801,000 | -39.3% | 77,156 | -45.8% | 0.00% | – |
| Q2 2019 | $1,319,000 | -8.2% | 142,427 | -9.4% | 0.00% | – |
| Q1 2019 | $1,437,000 | -16.7% | 157,275 | -49.3% | 0.00% | – |
| Q4 2018 | $1,726,000 | -55.7% | 309,905 | -5.3% | 0.00% | -100.0% |
| Q3 2018 | $3,897,000 | +16.5% | 327,214 | -0.1% | 0.00% | 0.0% |
| Q2 2018 | $3,344,000 | -21.3% | 327,479 | +0.1% | 0.00% | 0.0% |
| Q1 2018 | $4,248,000 | +40.8% | 327,280 | +5.6% | 0.00% | – |
| Q4 2017 | $3,016,000 | -33.6% | 309,956 | +0.4% | 0.00% | -100.0% |
| Q3 2017 | $4,543,000 | – | 308,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |